DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
Introduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method. The use of 3-month injectable contraceptives also has drawbacks or side effe...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2021-10-01
|
Series: | Journal of Vocational Nursing |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/JoViN/article/view/30327 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841560048628662272 |
---|---|
author | Amellia Mardhika Yolanda Dwi Safitri Lailatul Fadliyah Riris Medawati |
author_facet | Amellia Mardhika Yolanda Dwi Safitri Lailatul Fadliyah Riris Medawati |
author_sort | Amellia Mardhika |
collection | DOAJ |
description | Introduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method. The use of 3-month injectable contraceptives also has drawbacks or side effects, one of which is menstrual cycle disorders. The purpose of this study was to determine the description of menstrual cycle disorders in users of 3-month injectable contraceptives. Methods: This study used a descriptive design. The population in this study was women of childbearing age who used injection contraception for 3-months at the sub-health center of Tanjung Village. The total population in this study was 48 samples. The sampling technique was carried out by the total sampling technique. The statistical analysis used in this study was descriptive analysis (number and prosentase). Results: The results of the study showed that using 3-month injectable contraceptives were found that 29 respondents (60.4%) experienced amenorrhea, 15 respondents (31.3%) spotting, and 4 respondents (8.3%) did not experience menstrual cycle disorders. Conclusion: Most users of 3-month injectable contraceptives experience amenorrhea. |
format | Article |
id | doaj-art-9040613ceaae4895997113ce6dd6d344 |
institution | Kabale University |
issn | 2775-0280 2722-7251 |
language | English |
publishDate | 2021-10-01 |
publisher | Universitas Airlangga |
record_format | Article |
series | Journal of Vocational Nursing |
spelling | doaj-art-9040613ceaae4895997113ce6dd6d3442025-01-05T05:30:08ZengUniversitas AirlanggaJournal of Vocational Nursing2775-02802722-72512021-10-01229710010.20473/jovin.v2i2.3032724810DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERSAmellia Mardhika0Yolanda Dwi Safitri1Lailatul Fadliyah2Riris Medawati3(Sinta ID: 6719524 ; H-index: 0); Faculty of Vocational Studies, Universitas AirlanggaFaculty of Vocational Studies, Universitas AirlanggaFaculty of Vocational Studies, Universitas AirlanggaFaculty of Vocational Studies, Universitas AirlanggaIntroduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method. The use of 3-month injectable contraceptives also has drawbacks or side effects, one of which is menstrual cycle disorders. The purpose of this study was to determine the description of menstrual cycle disorders in users of 3-month injectable contraceptives. Methods: This study used a descriptive design. The population in this study was women of childbearing age who used injection contraception for 3-months at the sub-health center of Tanjung Village. The total population in this study was 48 samples. The sampling technique was carried out by the total sampling technique. The statistical analysis used in this study was descriptive analysis (number and prosentase). Results: The results of the study showed that using 3-month injectable contraceptives were found that 29 respondents (60.4%) experienced amenorrhea, 15 respondents (31.3%) spotting, and 4 respondents (8.3%) did not experience menstrual cycle disorders. Conclusion: Most users of 3-month injectable contraceptives experience amenorrhea.https://e-journal.unair.ac.id/JoViN/article/view/30327injectable contraceptivesmenstruationamenorrheaspotting |
spellingShingle | Amellia Mardhika Yolanda Dwi Safitri Lailatul Fadliyah Riris Medawati DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS Journal of Vocational Nursing injectable contraceptives menstruation amenorrhea spotting |
title | DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS |
title_full | DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS |
title_fullStr | DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS |
title_full_unstemmed | DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS |
title_short | DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS |
title_sort | description of menstrual cycle disorders in 3 months injectable contraceptive users |
topic | injectable contraceptives menstruation amenorrhea spotting |
url | https://e-journal.unair.ac.id/JoViN/article/view/30327 |
work_keys_str_mv | AT amelliamardhika descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers AT yolandadwisafitri descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers AT lailatulfadliyah descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers AT rirismedawati descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers |